These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 1562726)

  • 21. A kinetic analysis of the interaction of human recombinant tissue factor pathway inhibitor with factor Xa utilizing and immunoassay and the effect of antithrombin III/heparin on the complex formation.
    Kamikubo Y; Hamuro T; Takemoto S; Nakahara Y; Kamei S; Nakagaki T; Miyamoto S; Funatsu A; Kato H
    Thromb Res; 1998 Feb; 89(4):179-86. PubMed ID: 9651145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant tissue factor pathway inhibitor enhances the binding of factor Xa to human monocytes.
    Li A; Chang AC; Peer GT; Wun TC; Taylor FB
    Thromb Haemost; 2001 May; 85(5):830-6. PubMed ID: 11372676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The lipoprotein-associated coagulation inhibitor.
    Broze GJ; Girard TJ; Novotny WF
    Prog Hemost Thromb; 1991; 10():243-68. PubMed ID: 2008533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of regions distal to glycine-160 to the anticoagulant activity of tissue factor pathway inhibitor.
    Lockett JM; Mast AE
    Biochemistry; 2002 Apr; 41(15):4989-97. PubMed ID: 11939795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant full-length tissue factor pathway inhibitor fails to bind to the cell surface: implications for catabolism in vitro and in vivo.
    Ho G; Narita M; Broze GJ; Schwartz AL
    Blood; 2000 Mar; 95(6):1973-8. PubMed ID: 10706863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoaffinity purification and characterization of lipoprotein-associated coagulation inhibitors from Hep G2 hepatoma, Chang liver, and SK hepatoma cells. A comparative study.
    Wun TC; Huang MD; Kretzmer KK; Palmier MO; Day KC; Bulock JW; Fok KF; Broze GJ
    J Biol Chem; 1990 Sep; 265(27):16096-101. PubMed ID: 2168880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action.
    Broze GJ; Warren LA; Novotny WF; Higuchi DA; Girard JJ; Miletich JP
    Blood; 1988 Feb; 71(2):335-43. PubMed ID: 3422166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics of the inhibition of tissue factor-factor VIIa by tissue factor pathway inhibitor.
    Lindhout T; Franssen J; Willems G
    Thromb Haemost; 1995 Sep; 74(3):910-5. PubMed ID: 8571320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of tissue factor-induced signaling by endogenous and recombinant tissue factor pathway inhibitor 1.
    Ahamed J; Belting M; Ruf W
    Blood; 2005 Mar; 105(6):2384-91. PubMed ID: 15550483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiological concentrations of tissue factor pathway inhibitor do not inhibit prothrombinase.
    Mast AE; Broze GJ
    Blood; 1996 Mar; 87(5):1845-50. PubMed ID: 8634431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human recombinant tissue-factor pathway inhibitor prevents the proliferation of cultured human neonatal aortic smooth muscle cells.
    Kamikubo Y; Nakahara Y; Takemoto S; Hamuro T; Miyamoto S; Funatsu A
    FEBS Lett; 1997 Apr; 407(1):116-20. PubMed ID: 9141493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor.
    van 't Veer C; Hackeng TM; Delahaye C; Sixma JJ; Bouma BN
    Blood; 1994 Aug; 84(4):1132-42. PubMed ID: 8049429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amino acid sequence and inhibitory activity of rhesus monkey tissue factor pathway inhibitor (TFPI): comparison with human TFPI.
    Kamei S; Kamikubo Y; Hamuro T; Fujimoto H; Ishihara M; Yonemura H; Miyamoto S; Funatsu A; Enjyoji K; Abumiya T
    J Biochem; 1994 Apr; 115(4):708-14. PubMed ID: 8089087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces. Evidence that rEPI can bind to and inhibit factor VIIa-tissue factor complexes in the absence of factor Xa.
    Callander NS; Rao LV; Nordfang O; Sandset PM; Warn-Cramer B; Rapaport SI
    J Biol Chem; 1992 Jan; 267(2):876-82. PubMed ID: 1730676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous presence of tissue factor pathway inhibitor (TFPI) and low molecular weight heparin has a synergistic effect in different coagulation assays.
    Valentin S; Ostergaard P; Kristensen H; Nordfang O
    Blood Coagul Fibrinolysis; 1991 Oct; 2(5):629-35. PubMed ID: 1664252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory properties of separate recombinant Kunitz-type-protease-inhibitor domains from tissue-factor-pathway inhibitor.
    Petersen LC; Bjørn SE; Olsen OH; Nordfang O; Norris F; Norris K
    Eur J Biochem; 1996 Jan; 235(1-2):310-6. PubMed ID: 8631347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extrinsic pathway inhibitor (EPI) released to the blood by heparin is a more powerful coagulation inhibitor than is recombinant EPI.
    Lindahl AK; Abildgaard U; Larsen ML; Staalesen R; Hammer AK; Sandset PM; Nordfang O; Beck TC
    Thromb Res; 1991 Jun; 62(6):607-14. PubMed ID: 1926055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineered recombinant factor VII Q217 variants with altered inhibitor specificities.
    Chang YJ; Hamaguchi N; Chang SC; Ruf W; Shen MC; Lin SW
    Biochemistry; 1999 Aug; 38(34):10940-8. PubMed ID: 10460149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacterial expression, purification, and partial characterization of amino acids 94-155 of human tissue factor pathway inhibitor (TFPI) as an inhibitor of blood coagulation factor Xa.
    Day KC; Welsch DJ
    Thromb Res; 1992 Dec; 68(4-5):369-81. PubMed ID: 1290165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deletion of the membrane anchoring region of tissue factor abolishes autoactivation of factor VII but not cofactor function. Analysis of a mutant with a selective deficiency in activity.
    Neuenschwander PF; Morrissey JH
    J Biol Chem; 1992 Jul; 267(20):14477-82. PubMed ID: 1629232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.